Bruce A. Andrien Jr.

Person

Guilford, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-C5 antibodies having improved pharmacokinetics
- Patent number 11,434,280
- Issue date Sep 6, 2022
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating atypical hemolytic uremic syndrome and paroxysm...
- Patent number 10,584,164
- Issue date Mar 10, 2020
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating atypical hemolytic uremic syndrome with anti-C5...
- Patent number 10,227,400
- Issue date Mar 12, 2019
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-C5 antibodies having improved pharmacokinetics
- Patent number 9,803,007
- Issue date Oct 31, 2017
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-C5 antibodies having improved pharmacokinetics
- Patent number 9,663,574
- Issue date May 30, 2017
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-C5 antibodies having improved pharmacokinetics
- Patent number 9,371,377
- Issue date Jun 21, 2016
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding anti-C5 antibodies having improved pharmacok...
- Patent number 9,206,251
- Issue date Dec 8, 2015
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating C5 mediated complement-associated conditions wi...
- Patent number 9,107,861
- Issue date Aug 18, 2015
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-C5 antibodies having improved pharmacokinetics
- Patent number 9,079,949
- Issue date Jul 14, 2015
- Alexion Pharmaceuticals, Inc.
- Bruce A. Andrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
KIDNEY ACTIVE FUSION PROTEINS AND METHODS OF TREATMENT USING THE SAME
- Publication number 20240262877
- Publication date Aug 8, 2024
- Alexion Pharmaceuticals, Inc.
- Keith Bouchard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
- Publication number 20240141024
- Publication date May 2, 2024
- Alexion Pharmaceuticals, Inc.
- Bruce A. ANDRIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS
- Publication number 20220324952
- Publication date Oct 13, 2022
- Alexion Pharmaceuticals, Inc.
- Bruce Andrien
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
- Publication number 20200157200
- Publication date May 21, 2020
- Alexion Pharmaceuticals, Inc.
- Bruce A. ANDRIEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
- Publication number 20190263897
- Publication date Aug 29, 2019
- Alexion Pharmaceuticals, Inc.
- Bruce A. ANDRIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
- Publication number 20180009885
- Publication date Jan 11, 2018
- Alexion Pharmaceuticals, Inc.
- Bruce A. ANDRIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
- Publication number 20170298123
- Publication date Oct 19, 2017
- Alexion Pharmaceuticals, Inc.
- Bruce A. ANDRIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS
- Publication number 20170073399
- Publication date Mar 16, 2017
- Alexion Pharmaceuticals, Inc.
- Bruce Andrien
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
- Publication number 20160251433
- Publication date Sep 1, 2016
- Alexion Pharmaceuticals, Inc.
- Bruce A. ANDRIEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY AN INF...
- Publication number 20160168237
- Publication date Jun 16, 2016
- Alexion Pharmaceuticals, Inc.
- Darrell Fontenot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
- Publication number 20160108115
- Publication date Apr 21, 2016
- Alexion Pharmaceuticals, Inc.
- Bruce A. ANDRIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
- Publication number 20150299305
- Publication date Oct 22, 2015
- Alexion Pharmaceuticals, Inc.
- Bruce A. ANDRIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Bruce A. Andrien Jr.

Person

Patents Grantslast 30 patents

Anti-C5 antibodies having improved pharmacokinetics

Methods of treating atypical hemolytic uremic syndrome and paroxysm...

Methods of treating atypical hemolytic uremic syndrome with anti-C5...

Anti-C5 antibodies having improved pharmacokinetics

Anti-C5 antibodies having improved pharmacokinetics

Anti-C5 antibodies having improved pharmacokinetics

Nucleic acids encoding anti-C5 antibodies having improved pharmacok...

Methods of treating C5 mediated complement-associated conditions wi...

Anti-C5 antibodies having improved pharmacokinetics

Patents Applicationslast 30 patents

KIDNEY ACTIVE FUSION PROTEINS AND METHODS OF TREATMENT USING THE SAME

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

METHOD FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY AN INF...

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS